# Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig

> **NIH NIH N43** · GLYCOSCIENTIFIC, LLC · 2023 · $600,000

## Abstract

GlycoScientific proposes to generate antibodies specific for six inflammatory cytokines to elucidate and correlate immunological markers of tuberculosis (TB) transmission and disease development in the guinea pig. Once the antibodies are produced, the Offeror will use them to evaluate the cytokines in TB infected and non-infected guinea pigs. The production of these crucial immunological reagents will greatly enhance our understanding of basic immune responses to TB infection in naturally infected mammalian models.

## Key facts

- **NIH application ID:** 10933281
- **Project number:** 75N93023C00038-0-9999-1
- **Recipient organization:** GLYCOSCIENTIFIC, LLC
- **Principal Investigator:** MARLA POPOV
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $600,000
- **Award type:** —
- **Project period:** 2023-09-01 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10933281

## Citation

> US National Institutes of Health, RePORTER application 10933281, Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig (75N93023C00038-0-9999-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10933281. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*